BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21143466)

  • 1. Treatment of cutaneous sarcoid with topical gel psoralen and ultraviolet A.
    Gleeson CM; Morar N; Staveley I; Bunker CB
    Br J Dermatol; 2011 Apr; 164(4):892-4. PubMed ID: 21143466
    [No Abstract]   [Full Text] [Related]  

  • 2. Bath psoralen plus ultraviolet A for hidradenitis suppurativa: a review of 13 patients.
    Shareef M; Dawe R
    Br J Dermatol; 2011 Apr; 164(4):895-6. PubMed ID: 21166664
    [No Abstract]   [Full Text] [Related]  

  • 3. Photo(chemo)therapy for vitiligo.
    Pacifico A; Leone G
    Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):261-77. PubMed ID: 21950634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of plaque-type localized scleroderma with retinoic acid and ultraviolet A plus the photosensitizer psoralen: a case series.
    Ozdemir M; Engin B; Toy H; Mevlitoglu I
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):519-21. PubMed ID: 18363929
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of the preferences of patients with psoriasis between systemic psoralen plus ultraviolet A and bath psoralen plus ultraviolet A.
    Alshiyab D; Chin MF; Edwards C; Anstey AV
    Br J Dermatol; 2015; 172(5):1457-8. PubMed ID: 25420468
    [No Abstract]   [Full Text] [Related]  

  • 6. British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015.
    Ling TC; Clayton TH; Crawley J; Exton LS; Goulden V; Ibbotson S; McKenna K; Mohd Mustapa MF; Rhodes LE; Sarkany R; Dawe RS
    Br J Dermatol; 2016 Jan; 174(1):24-55. PubMed ID: 26790656
    [No Abstract]   [Full Text] [Related]  

  • 7. The contribution of medical physics to the development of psoralen photochemotherapy (PUVA) in the UK: a personal reminiscence.
    Diffey B
    Phys Med Biol; 2006 Jul; 51(13):R229-44. PubMed ID: 16790905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoralen photochemotherapy.
    McClelland PB; Morgan P; Leach EE; Shelk J
    Dermatol Nurs; 1997 Dec; 9(6):403-15; quiz 416-7. PubMed ID: 9460332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoralen and ultraviolet a light therapy for psoriasis.
    Stern RS
    N Engl J Med; 2007 Aug; 357(7):682-90. PubMed ID: 17699818
    [No Abstract]   [Full Text] [Related]  

  • 10. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
    McGinnis KS; Shapiro M; Vittorio CC; Rook AH; Junkins-Hopkins JM
    Arch Dermatol; 2003 Jun; 139(6):771-5. PubMed ID: 12810509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous lesions in Bazex syndrome and successful treatment with oral psoralen phototherapy.
    Gill D; Fergin P; Kelly J
    Australas J Dermatol; 2001 Nov; 42(4):278-80. PubMed ID: 11903162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Science and (Lost) Art of Psoralen Plus UVA Phototherapy.
    Richard EG
    Dermatol Clin; 2020 Jan; 38(1):11-23. PubMed ID: 31753184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical psoralen-ultraviolet A therapy for palmoplantar dermatoses: experience with 35 consecutive patients.
    Davis MD; McEvoy MT; el-Azhary RA
    Mayo Clin Proc; 1998 May; 73(5):407-11. PubMed ID: 9581579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cutaneous plasmacytosis with mask-bath PUVA: A therapeutic option.
    Mok ZR; Tan ES; Chong WS
    Australas J Dermatol; 2017 Feb; 58(1):e1-e4. PubMed ID: 26080730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising therapeutic option for cutaneous plasmacytosis: 308-nm excimer lamp.
    Omura R; Sowa-Osako J; Fukai K; Kusutani N; Takeoka Y; Koh H; Ohsawa M; Iwatsuki K; Tsuruta D; Hamada T
    J Dermatol; 2018 Aug; 45(8):e215-e216. PubMed ID: 29464763
    [No Abstract]   [Full Text] [Related]  

  • 19. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
    Pozo-Román T; González-López A; Velasco-Vaquero ME; Núñez-Cabezón M
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):136-42. PubMed ID: 16441619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichenoid type of cutaneous sarcoidosis: great response to topical tacrolimus.
    Vano-Galvan S; Fernandez-Guarino M; Carmona LP; Harto A; Carrillo R; Jaén P
    Eur J Dermatol; 2008; 18(1):89-90. PubMed ID: 18086604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.